How Research Tools and Enzymes Became Fundamental Components of Molecular Diagnostic Solutions

How Research Tools and Enzymes Became Fundamental Components of Molecular Diagnostic Solutions

Matthieu Lewis
Takara Bio, France

Abstract
Takara Bio, a leading global biotechnology company, has decades of experience in the research and development of high-quality enzymes and solutions for DNA and RNA-based molecular diagnostics. The company’s expertise in this field has been instrumental in the fight against infectious diseases by providing the necessary tools and technologies for the rapid detection and surveillance of pathogens. Through active collaboration with scientists and utilizing their own R&D capabilities, Takara Bio has recently developed faster and more efficient protocols for the detection of various infectious agents, particularly relevant as PCR technology becomes more widely accessible for disease testing. This presentation highlights the importance of research tools and enzymes in the development of molecular diagnostic solutions, specifically in terms of enhancing the sensitivity and specificity of diagnostic tests. Additionally, Takara showcases the scientific community’s vital role in advancing disease testing, and how they continue to work closely with scientists, engineers, and healthcare professionals to develop new and innovative solutions for disease detection and diagnosis.

Back to GQ2023 session page Back to GQ2023 overview page
Bookmark the permalink.

Comments are closed.